Unlock stock picks and a broker-level newsfeed that powers Wall Street.
Frankfurt - Delayed Quote EUR

XP Chemistries AB (publ) (86Q.F)

Compare
0.0100
-0.0015
(-13.04%)
At close: April 4 at 3:29:02 PM GMT+2
Loading Chart for 86Q.F
  • Previous Close 0.0115
  • Open 0.0115
  • Bid 0.0120 x --
  • Ask 0.0130 x --
  • Day's Range 0.0100 - 0.0115
  • 52 Week Range 0.0020 - 0.0160
  • Volume 100,000
  • Avg. Volume 0
  • Market Cap (intraday) 2.426M
  • Beta (5Y Monthly) 1.36
  • PE Ratio (TTM) --
  • EPS (TTM) -0.0000
  • Earnings Date --
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

XP Chemistries AB (publ), a biotechnology company, develops and produces forest-based capsaicin and analogues. It offers animal feed ingredients, personal care and cosmetic ingredients, pure capsaicinoids, and self-defense spray ingredients. The company was incorporated in 2018 and is based in Sundsvall, Sweden.

www.xpchemistries.com

2

Full Time Employees

December 31

Fiscal Year Ends

Chemicals

Industry

Recent News: 86Q.F

View More

Performance Overview: 86Q.F

Trailing total returns as of 4/4/2025, which may include dividends or other distributions. Benchmark is OMX Stockholm 30 Index (^OMX) .

YTD Return

86Q.F
53.85%
OMX Stockholm 30 Index (^OMX)
7.89%

1-Year Return

86Q.F
300.00%
OMX Stockholm 30 Index (^OMX)
9.30%

3-Year Return

86Q.F
94.41%
OMX Stockholm 30 Index (^OMX)
7.06%

5-Year Return

86Q.F
97.33%
OMX Stockholm 30 Index (^OMX)
62.84%

Compare To: 86Q.F

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: 86Q.F

View More

Valuation Measures

Annual
As of 4/4/2025
  • Market Cap

    2.43M

  • Enterprise Value

    2.23M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    40.13

  • Price/Book (mrq)

    1.00

  • Enterprise Value/Revenue

    84.91

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    0.00%

  • Return on Assets (ttm)

    -22.36%

  • Return on Equity (ttm)

    -30.19%

  • Revenue (ttm)

    283.94k

  • Net Income Avi to Common (ttm)

    -7.13M

  • Diluted EPS (ttm)

    -0.0000

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    2.15M

  • Total Debt/Equity (mrq)

    --

  • Levered Free Cash Flow (ttm)

    -5.27M

Research Analysis: 86Q.F

View More

Company Insights: 86Q.F

Research Reports: 86Q.F

View More

People Also Watch